MHRA Safety Roundup: September 2026

Summary

The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices and blood components for transfusion in the UK. This roundup provides a summary of their latest safety advice for medicines and medical device users. It includes details of medicine recalls, medical device field safety notices and details of how to report drug reactions and device incidents.

Content

This month's Safety Roundup includes: 

• National Patient Safety Alert on Patient hoists and slings (all types): risk of death and serious harm from falls (NatPSA/2026/005/MHRA) 

• Device Safety Information on Radiofrequency (RF) Safety Considerations for Wireless Cardiotocography (CTG) Monitoring Systems (DSI/2026/012) 

• Device Safety Information / Drug Safety Update on Filters should be used during the administration of Parenteral Nutrition for patients in all care settings  

• Letters, medicines recalls and device notifications sent to healthcare professionals in September 2026  

• News and guidance on: 

  • Fluenz; be aware of increased risk of fainting following administration 

  • Intra-articular Steroid Injections: Reminder of the risks of Anaphylactic Reactions 

  • Apalutamide and enzalutamide: laboratory test interference leading to falsely elevated digoxin plasma level results

  • Publication of flu vaccine factsheet